- Home
- EVMN vs EQBK Comparison
EVMN vs EQBK Comparison
Compare EVMN & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVMN | EQBK |
|---|---|---|
| Founded | 2020 | 2002 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 932.4M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | EVMN | EQBK |
|---|---|---|
| Price | $22.86 | $45.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $43.88 | ★ $51.33 |
| AVG Volume (30 Days) | ★ 341.8K | 68.6K |
| Earning Date | 06-11-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.59% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.80 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.58 |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | $57.28 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $36.04 |
| 52 Week High | $33.20 | $50.07 |
Technical Indicators
Market Signals| Indicator | EVMN | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 54.89 |
| Support Level | $21.39 | $44.38 |
| Resistance Level | $23.08 | $46.99 |
| Average True Range (ATR) | 1.43 | 0.87 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 45.87 | 59.25 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 77 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.